BIOTIME INC License Agreements
19 Contracts & Agreements
- Second Amendment to Hadasit License dated December 1, 2019 (Filed With SEC on March 10, 2022)
- First Amendment to License Agreement dated April 16, 2021 between Cancer Research Technology Limited and Registrant (Filed With SEC on August 12, 2021)
- Amendment, dated January 8, 2018, to Second Amended and Restated License Agreement, dated June 15, 2017, between Cell Cure Neurosciences, Ltd. and Hadasit Medical Research... (Filed With SEC on March 15, 2018)
- License Agreement, dated August 17, 2017, between BioTime, Inc. and AgeX Therapeutics, Inc (Filed With SEC on November 9, 2017)
- Second Amended and Restated License Agreement, dated June 15, 2017, between Cell Cure Neurosciences, Ltd. and Hadasit Medical Research Services and Development Ltd. (Portions of... (Filed With SEC on August 9, 2017)
- Second Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on August 9, 2016)
- First Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on March 15, 2016)
- License Agreement, dated January 22, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Portions of this exhibit have been omitted pursuant to a... (Filed With SEC on March 15, 2016)
- Cross License Agreement between Asterias Biotherapeutics, Inc., BioTime, Inc. and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)
- License Agreement, dated September 29, 2015, between OrthoCyte Corporation and Heraeus Medical GmbH (Portions of this exhibit have been omitted pursuant to a request for... (Filed With SEC on November 9, 2015)
- Exclusive License Agreement, dated February 15, 2006, between Glycosan BioSystems, Inc. and the University of Utah Research Foundation, as amended (Filed With SEC on November 9, 2012)
- License Option Agreement, dated December 15, 2011 between BioTime, Inc. and USCN Life Sciences, Inc. (Portions of this exhibit have been omitted pursuant to a request for... (Filed With SEC on March 14, 2012)
- License Agreement between BioTime, Inc. and Cornell University (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on November 8, 2011)
- License Agreement, dated February 15, 2006, between the University of Utah and Glycosan BioSystems, Inc., and amendments thereto (Filed With SEC on May 5, 2011)
- Exclusive License Agreement, dated November 20, 2007, between Cell Targeting, Inc. and Burnham Institute for Medical Research (Filed With SEC on March 15, 2011)
- Amended and Restated Research and License Agreement, dated October 7, 2010, between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on March 15, 2011)
- Research and Exclusive License Option Agreement, dated October 7, 2010, between Teva Pharmaceutical Industries, Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit... (Filed With SEC on March 15, 2011)
- LICENSE, PRODUCT PRODUCTION,AND DISTRIBUTION AGREEMENT (Filed With SEC on August 14, 2008)
- Commercial License and Option Agreement between BioTime and Wisconsin Alumni Research Foundation (Filed With SEC on January 9, 2008)
